Lv4
566 积分 2024-05-09 加入
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
2天前
已完结
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes
7天前
已完结
Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity
7天前
已完结
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
8天前
已完结
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
8天前
已完结
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes
8天前
已完结
31st European Congress on Obesity (ECO 2024)
10天前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
1个月前
已完结
The effect of GLP‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
4个月前
已完结
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
4个月前
已完结
皖公网安备34019202002308
